SOURCE: Equity News Circuit

Equity News Circuit

May 02, 2013 08:00 ET

Squawk Box Stocks Reports On: Xumanii Inc. (OTCQB: XUII), Lot78, Inc. (OTCQB: LOTE), iTalk Inc. (OTCQB: TALK), Titan Pharmaceuticals, Inc. (OTCQB: TTNP)

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - May 2, 2013) - Xumanii (OTCQB: XUII), Lot78, Inc. (OTCQB: LOTE), iTalk Inc. (OTCQB: TALK), Titan Pharmaceuticals, Inc. (OTCQB: TTNP).

Xumanii Inc. (XUII) saw shares advancing 199.5% or $0.1995 per share to close at $0.2995 on volume of 37,132,425 shares traded during Wednesday's trading session. The broadcasting company with patent pending technology was the biggest winner on Wall Street yesterday. Will shares of Xumanii continue to rise or will traders begin to lock in profits? Find out what to expect next in our exclusive research report at: http://squawkboxstocks.com/reports/XUII

Lot78, Inc. (LOTE) saw shares rising 9.09% to close yesterday's trading session at $9.00 on volume of 546,410 shares traded. The urban apparel company continued its impressive winning streak by posting its fifth straight positive day. With shares now up 231% over the past five days will investors finally look to lock in their profits of will the stock continue to squeeze short sellers higher? Find out more in our exclusive research report at: http://squawkboxstocks.com/reports/LOTE

iTalk Inc. (TALK) saw shares advancing 11.76% or $0.12 per share to close yesterday at $1.14 on volume of 2,308,478 shares traded. Wednesday morning the company announced that it has launched its mobile broadband data service. The new service, which runs on the Nationwide Sprint Network, covers 97% of the United States to over 280 million people in 12,900 cities. How high could shares of iTalk climb on this positive announcement? Find out our thoughts in our exclusive research report at: http://squawkboxstocks.com/reports/TALK

Titan Pharmaceuticals, Inc. (TTNP) saw shares declining 73.98% or $1.228 per share to close yesterday at $0.432 on volume of 16,401,347 shares traded. The biopharmaceutical company reported that U.S. health regulators rejected the Titan's experimental drug to treat opioid addiction and asked for additional data showing it works. Will shares of Titan recover following this negative report or continue to trade lower? Find out our thoughts in our exclusive research report at: http://squawkboxstocks.com/reports/TTNP

About http://SquawkBoxStocks.com

Squawk Box Stocks offers its daily stock alerts and market content newsletter to investors looking for timely information available! Our experienced team provides you only the best stock alerts & research reports delivered to your email inbox for FREE. Our track record of providing winning alerts has won us the trust of thousands of investors worldwide. With our dedicated research team & investor database continuing to grow we have become a leading destination for the most profitable opportunities that are available in today's stock market. To receive our FREE, comprehensive newsletter, visit http://SquawkBoxStocks.com.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Winning Media LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information

  • Contact Information:
    Winning Media LLC
    1-800-411-7716
    Email Contact